HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Frequent, effective communication may minimize ‘financial toxicity’ of cancer treatments
-
- Navigating the National Health System: A personal experience Jai N. Patel, PharmD, BCOP, CPP
- Physicians, patients should ‘reflectively reject’ coverage, treatment recommendations based on ICER myeloma report Rafael Fonseca, MD
- $1 million gift establishes professorship in women’s cancers at City of Hope
- 21st Century Oncology appoints research director
- Adcetris superior to standard therapy for cutaneous T-cell lymphoma
- ASH honors medical students, residents
- ASH presents bridge grants to nine investigators
- Association of American Cancer Institutes elects new vice president
-
- ASTRO elects five board members
- Bayer awards grants for research into hemophilia, bleeding disorders
- CRLX101 combination fails to extend PFS in patients with renal cell carcinoma
- Custirsen fails to extend OS in metastatic castrate-resistant prostate cancer
- ENMD-2076 trial meets endpoint for fibrolamellar carcinoma
- Foundation provides awards to physician–scientists
- National initiative establishes research priorities for VTE in cancer
- Pfizer to acquire Medivation for $14 billion
-
- Radiopaque bead treatment at Mount Sinai ‘potential game-changer’ for hepatocellular carcinoma
- Rise in HPV-associated cancers among men reflects low vaccination rates
- Scientists receive grants for pancreatic cancer research
- Two NSCLC trials fail to meet primary endpoints
- University of Kansas appoints radiation oncology chair
- Vanderbilt-Ingram Cancer Center selects director for early detection, prevention initiative
- Treating the primary in metastatic prostate cancer Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
- FDA approves Sustol to prevent chemotherapy-induced nausea and vomiting
-
- FDA grants orphan drug designation to CD4CAR therapy for peripheral T-cell lymphoma
- FDA grants ribociclib breakthrough therapy designation for advanced breast cancer
- Physician responsibilities for suspected Medicare overpayments
- Alemtuzumab shows promise for T-cell large granular lymphocytic leukemia
- Annual FIT associated with high sensitivity, adherence to follow-up screens
- Anthracycline chemotherapy does not increase risk for long-term cognitive decline
- Assessment tool may identify older patients at risk for chemotherapy toxicity
- Black patients, uninsured less likely to receive chemotherapy for HIV–associated lymphoma
-
- Bortezomib-pegylated liposomal doxorubicin combination fails to improve survival in multiple myeloma
- Breast, thyroid cancer survivors at risk for developing other malignancy
- Breastfeeding may protect against aggressive breast cancers
- Carfilzomib combination extends PFS in high-risk multiple myeloma regardless of cytogenetic status
- Childhood cancer survivors report feeling older than actual age
- Combined oral contraceptives increase risk for VTE in women with severe thrombophilia
- Corticosteroid prophylaxis reduces acute GVHD after haploidentical HSCT
- Cumulative cisplatin dose linked to hearing loss among testicular cancer survivors
-
- Delirium frequently underdiagnosed in patients with advanced cancers
- Diet, exercise decrease biomarkers associated with cancer development
- Dose-sparing schedule may prolong response with IV romidepsin for cutaneous T-cell lymphoma
- Dying at home does not hasten death among patients with cancer
- Early decline in sexual functioning common among male pediatric ALL survivors
- Edoxaban noninferior to warfarin for cancer, VTE
- Eribulin improves survival for patients with advanced sarcomas, but questions remain
- Former cigarette smokers may still need lung cancer screening
-
- Genetic, clinical risk factors identified for pancreatitis in ALL
- Guideline sets standard for adequate margins in ductal carcinoma in situ
- HIV patients less likely to receive treatment for many cancers
- Immunochemotherapy, autologous HSCT double time to treatment failure in mantle cell lymphoma
- Long-term Ewing’s sarcoma survivors still face high mortality risk
- Minimally invasive genomic profiling may improve treatment of advanced prostate cancer
- More extensive resection improves survival for patients with glioblastoma multiforme
- Online information on pancreatic cancer often above reading level of general population
-
- Opinions on prognosis often discordant between patients and their oncologists
- Palliative care associated with negative stigma, impending death
- PD-L1 expression may predict immunotherapy response in cervical, vulvar squamous cell carcinoma
- Prostate radiotherapy, ADT may extend metastatic prostate cancer survival
- PSA levels in midlife predict future prostate cancer mortality
- Racial, socioeconomic factors associated with pediatric nasopharyngeal cancer diagnosis
- Radiosurgery alone lessens cognitive decline for patients with limited brain metastases
- Resistant E. coli, E. faecium CLABSIs prevalent among oncology settings
-
- rVIII-SingleChain appears safe, effective for severe hemophilia A
- School-based HPV vaccination program reduces risk for precancerous lesions among female students
- Studies highlight potential for genomic testing in pediatric cancers
- Supportive care medications, palliative services underused by black women with breast cancer
- Surgeon’s proficiency in esophagectomy affects short- and long-term cancer outcomes
- Time to colonoscopy following positive fecal blood test varies greatly
- Timing between thyroidectomy, radioactive iodine does not affect DTC outcomes
- TP53 status may predict response to VEGFR inhibition for advanced sarcoma
-
- Video-assisted thoracoscopic surgery for NSCLC reduces pain, improves quality of life
- Volasertib demonstrates antitumor activity without PFS benefit in ovarian cancer
- Zoledronic acid reduces skeletal complications for men with progressive bony prostate cancer
- Financial benefits do not explain survival improvement among married patients with cancer
- ‘Mystery shopper’ study reveals barriers to accessing palliative care
- Should clinicians prescribe treatments that are more affordable but possibly less effective?